The effect of a novel, digital physical activity and emotional well-being intervention on health-related quality of life in people with chronic kidney disease: trial design and baseline data from a multicentre prospective, wait-list randomised controlled trial (kidney BEAM)

C. G Walklin, Hannah M. L. Young, E. Asghari, S. Bhandari, R. E Billany, N. Bishop, K. Bramham, J. Briggs, J. O. Burton, J. Campbell, E. M Castle, J. Chilcot, N. Cooper, V Deelchand, M. P. M. Graham-Brown, A. Hamilton, M. Jesky, P. A. Kalra, P. Koufaki, K. MccaffertyA. C Nixon, H. Noble, Z. L. Saynor, C. Sothinathan, M. W. Taal, J. Tollitt, D. C. Wheeler, T. J. Wilkinson, J. H. MacDonald, S. A. Greenwood

Research output: Contribution to journalArticlepeer-review

15 Downloads (Pure)


Background: Physical activity and emotional self-management has the potential to enhance health-related quality of life (HRQoL), but few people with chronic kidney disease (CKD) have access to resources and support. The Kidney BEAM trial aims to evaluate whether an evidence-based physical activity and emotional wellbeing self-management programme (Kidney BEAM) leads to improvements in HRQoL in people with CKD.

Methods: This was a prospective, multicentre, randomised waitlist-controlled trial, with health economic analysis and nested qualitative studies. In total, three hundred and four adults with established CKD were recruited from 11 UK kidney units. Participants were randomly assigned to the intervention (Kidney BEAM) or a wait list control group (1:1). The primary outcome was the between-group difference in Kidney Disease Quality of Life (KDQoL) mental component summary score (MCS) at 12 weeks. Secondary outcomes included the KDQoL physical component summary score, kidney-specific scores, fatigue, life participation, depression and anxiety, physical function, clinical chemistry, healthcare utilisation and harms. All outcomes were measured at baseline and 12 weeks, with long-term HRQoL and adherence also collected at six months follow-up. A nested qualitative study explored experience and impact of using Kidney BEAM.

Results: 340 participants were randomised to Kidney BEAM (n = 173) and waiting list (n = 167) groups. There were 96 (55%) and 89 (53%) males in the intervention and waiting list groups respectively, and the mean (SD) age was 53 (14) years in both groups. Ethnicity, body mass, CKD stage, and history of diabetes and hypertension were comparable across groups. The mean (SD) of the MCS was similar in both groups, 44.7 (10.8) and 45.9 (10.6) in the intervention and waiting list groups respectively.

Conclusion: Results from this trial will establish whether the Kidney BEAM self management programme is a cost-effective method of enhancing mental and physical wellbeing of people with CKD.

Trial Registration: NCT04872933. Registered 5th May 2021.
Original languageEnglish
Article number122
Number of pages17
JournalBMC Nephrology
Issue number1
Publication statusPublished - 2 May 2023


  • KDQoL-SF
  • SF-36
  • e-health
  • Telemedicine
  • Digital health
  • Mixed-methods
  • Quality of life

Cite this